Multimodal management of diffuse neonatal hemangiomatosis [4] (multiple letters)

Journal of the American Academy of Dermatology

Volumn 37, Issue 6, 1997, Pages 1019-1021

  Blei, F ^a   Orlow, S J ^a   Geronemus, R ^a   Stratte, E G ^a   Tope, W D ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2 INTERFERON;

DRUG EFFECT; HEMANGIOMATOSIS; HUMAN; IMMUNOTHERAPY; LETTER; LEUKOMALACIA; NEUROTOXICITY; PRIORITY JOURNAL;

EID: 0031459941     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0190-9622(97)70097-5     Document Type: Letter

References (5)

1. RR Rickets RM Hatley BJ Corden H Sabio CG. Howell Interferon alpha 2a for the treatment of complex hemangiomas of infancy and childhood Ann Surg 219 1994 605 614
2. L Ohlms TJI McGill DT Jones GB. Healy Interferon alfa-2a therapy for airway hemangiomas Ann Rhinol Otolaryngol 103 1994 1 8
3. RAB Ezekowitz JB Mulliken J. Folkman Interferon alfa-2a therapy for life-threatening hemangiomas of infancy N Engl J Med 326 1992 1456 1463
4. F Blei SJ Orlow RG. Geronemus Interferon alfa-2a therapy for extensive perianal and lower extremity hemangioma J Am Acad Dermatol 29 1993 98 99
5. F Blei SJ Orlow RG. Geronemus Supraumbilical mid-abdominal raphe, sternal atresia, and hemangioma in an infant: response of hemangioma to laser and interferon alfa-2a Pediatr Dermatol 10 1993 71 76